
LogicBio is developing its proprietary gene therapy platform in order to provide lifelong cures for serious, early-onset rare diseases by combining the best of gene therapy and gene editing. Its GeneRide™ technology enables nuclease-free and promoterless site-specific integration of a therapeutic gene into the genome, allowing durable gene expression in dividing cells.
Additional Portfolio Companies